New Cancer Treatment Triples Cell Elimination in Lymphoma

A breakthrough "off-the-shelf" CAR-T therapy eliminated residual cancer cells three times more effectively than standard care in lymphoma patients.

The treatment could prevent cancer recurrence in high-risk patients for the first time.